My Quote Request
No products added yet
6505-01-318-7399
20 Products
NDC58887-0115-32
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187399
NSN
6505-01-318-7399
NDC58887-0115-32
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187399
NSN
6505-01-318-7399
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CLOMIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOMIPRAMINE HYDROCHLORIDE CAPSULES 25MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 CAPSULES PER PACKAGE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00078-0316-05
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187399
NSN
6505-01-318-7399
NDC00078-0316-05
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187399
NSN
6505-01-318-7399
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CLOMIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOMIPRAMINE HYDROCHLORIDE CAPSULES 25MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 CAPSULES PER PACKAGE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00078-0317-05
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187400
NSN
6505-01-318-7400
NDC00078-0317-05
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187400
NSN
6505-01-318-7400
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS CLOMIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOMIPRAMINE HYDROCHLORIDE CAPSULES 50MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC58887-0116-30
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187400
NSN
6505-01-318-7400
NDC58887-0116-30
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187400
NSN
6505-01-318-7400
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS CLOMIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOMIPRAMINE HYDROCHLORIDE CAPSULES 50MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
ANAFRANIL
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187402
NSN
6505-01-318-7402
ANAFRANIL
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187402
NSN
6505-01-318-7402
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MILLIGRAMS CLOMIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOMIPRAMINE HYDROCHLORIDE CAPSULES 75MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
ANAFRANIL CAPSULES
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187402
NSN
6505-01-318-7402
ANAFRANIL CAPSULES
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187402
NSN
6505-01-318-7402
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MILLIGRAMS CLOMIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOMIPRAMINE HYDROCHLORIDE CAPSULES 75MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00093-0796-01
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187402
NSN
6505-01-318-7402
NDC00093-0796-01
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187402
NSN
6505-01-318-7402
MFG
LEMMON CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MILLIGRAMS CLOMIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOMIPRAMINE HYDROCHLORIDE CAPSULES 75MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00093-0960-01
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187402
NSN
6505-01-318-7402
NDC00093-0960-01
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187402
NSN
6505-01-318-7402
MFG
LEMMON CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MILLIGRAMS CLOMIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOMIPRAMINE HYDROCHLORIDE CAPSULES 75MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00378-3075-01
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187402
NSN
6505-01-318-7402
NDC00378-3075-01
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187402
NSN
6505-01-318-7402
MFG
MYLAN PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MILLIGRAMS CLOMIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOMIPRAMINE HYDROCHLORIDE CAPSULES 75MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00406-9908-01
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187402
NSN
6505-01-318-7402
NDC00406-9908-01
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187402
NSN
6505-01-318-7402
MFG
MALLINCKRODT INC ANESTHESIA PRODUCTS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MILLIGRAMS CLOMIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOMIPRAMINE HYDROCHLORIDE CAPSULES 75MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00781-2047-01
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187402
NSN
6505-01-318-7402
NDC00781-2047-01
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187402
NSN
6505-01-318-7402
MFG
SANDOZ INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MILLIGRAMS CLOMIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOMIPRAMINE HYDROCHLORIDE CAPSULES 75MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC51672-4013-01
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187402
NSN
6505-01-318-7402
NDC51672-4013-01
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187402
NSN
6505-01-318-7402
MFG
TARO PHARMACEUTICALS USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MILLIGRAMS CLOMIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOMIPRAMINE HYDROCHLORIDE CAPSULES 75MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC52544-0596-01
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187402
NSN
6505-01-318-7402
NDC52544-0596-01
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187402
NSN
6505-01-318-7402
MFG
WATSON LABS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MILLIGRAMS CLOMIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOMIPRAMINE HYDROCHLORIDE CAPSULES 75MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC58887-0117-30
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187402
NSN
6505-01-318-7402
NDC58887-0117-30
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187402
NSN
6505-01-318-7402
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MILLIGRAMS CLOMIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOMIPRAMINE HYDROCHLORIDE CAPSULES 75MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
2G3535
CEFTAZIDIME INJECTION,USP
NSN, MFG P/N
6505013187405
NSN
6505-01-318-7405
MFG
BAXTER HEALTHCARE CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAM CEFTAZIDIME EQUIVALENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME SODIUM IN DEXTROSE INJECTION 50ML BAG 24S
III PROTECTIVE STORAGE FEATURE: FROZEN FOR PRESERVATION
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SPECIAL FEATURES: PREMIXED IN ISO-OSMOTIC SOLUTION 2.2 GRAMS DEXTROSE HYDOUS (TO ADJUST OSMOLALITY); FROZEN; SINGLE DOSE BAGE WITH HANGING DEVICE; ONE PERMANENTLY ATTACHED OUTLET PORT SHALL ACCEPT AND RETAIN PIERCING DEVICE OF STOCK LISTED IV ADMINSTRATION SETS; SECOND
TOTAL PRIMARY CONTAINER QUANTITY: 24
~1: OUTLET PORT IF PROVIDED,SHALL HAVE LATEX SLEEVE OR NATURAL RUBBER STOPPER AND SHALL BE SUITABLE FOR AN INJECTION
Related Searches:
FORTAZ
CEFTAZIDIME INJECTION,USP
NSN, MFG P/N
6505013187405
NSN
6505-01-318-7405
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAM CEFTAZIDIME EQUIVALENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME SODIUM IN DEXTROSE INJECTION 50ML BAG 24S
III PROTECTIVE STORAGE FEATURE: FROZEN FOR PRESERVATION
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SPECIAL FEATURES: PREMIXED IN ISO-OSMOTIC SOLUTION 2.2 GRAMS DEXTROSE HYDOUS (TO ADJUST OSMOLALITY); FROZEN; SINGLE DOSE BAGE WITH HANGING DEVICE; ONE PERMANENTLY ATTACHED OUTLET PORT SHALL ACCEPT AND RETAIN PIERCING DEVICE OF STOCK LISTED IV ADMINSTRATION SETS; SECOND
TOTAL PRIMARY CONTAINER QUANTITY: 24
~1: OUTLET PORT IF PROVIDED,SHALL HAVE LATEX SLEEVE OR NATURAL RUBBER STOPPER AND SHALL BE SUITABLE FOR AN INJECTION
Related Searches:
FORTAZ INJECTION PREMIXED
CEFTAZIDIME INJECTION,USP
NSN, MFG P/N
6505013187405
NSN
6505-01-318-7405
FORTAZ INJECTION PREMIXED
CEFTAZIDIME INJECTION,USP
NSN, MFG P/N
6505013187405
NSN
6505-01-318-7405
MFG
BAXTER HEALTHCARE CORP BAXTER SCIENTIFIC PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAM CEFTAZIDIME EQUIVALENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME SODIUM IN DEXTROSE INJECTION 50ML BAG 24S
III PROTECTIVE STORAGE FEATURE: FROZEN FOR PRESERVATION
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SPECIAL FEATURES: PREMIXED IN ISO-OSMOTIC SOLUTION 2.2 GRAMS DEXTROSE HYDOUS (TO ADJUST OSMOLALITY); FROZEN; SINGLE DOSE BAGE WITH HANGING DEVICE; ONE PERMANENTLY ATTACHED OUTLET PORT SHALL ACCEPT AND RETAIN PIERCING DEVICE OF STOCK LISTED IV ADMINSTRATION SETS; SECOND
TOTAL PRIMARY CONTAINER QUANTITY: 24
~1: OUTLET PORT IF PROVIDED,SHALL HAVE LATEX SLEEVE OR NATURAL RUBBER STOPPER AND SHALL BE SUITABLE FOR AN INJECTION
Related Searches:
NDC00173-0412-00
CEFTAZIDIME INJECTION,USP
NSN, MFG P/N
6505013187405
NSN
6505-01-318-7405
NDC00173-0412-00
CEFTAZIDIME INJECTION,USP
NSN, MFG P/N
6505013187405
NSN
6505-01-318-7405
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAM CEFTAZIDIME EQUIVALENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME SODIUM IN DEXTROSE INJECTION 50ML BAG 24S
III PROTECTIVE STORAGE FEATURE: FROZEN FOR PRESERVATION
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SPECIAL FEATURES: PREMIXED IN ISO-OSMOTIC SOLUTION 2.2 GRAMS DEXTROSE HYDOUS (TO ADJUST OSMOLALITY); FROZEN; SINGLE DOSE BAGE WITH HANGING DEVICE; ONE PERMANENTLY ATTACHED OUTLET PORT SHALL ACCEPT AND RETAIN PIERCING DEVICE OF STOCK LISTED IV ADMINSTRATION SETS; SECOND
TOTAL PRIMARY CONTAINER QUANTITY: 24
~1: OUTLET PORT IF PROVIDED,SHALL HAVE LATEX SLEEVE OR NATURAL RUBBER STOPPER AND SHALL BE SUITABLE FOR AN INJECTION
Related Searches:
NDC00182-3064-62
TRIAMCINOLONE DIACE
NSN, MFG P/N
6505013187461
NSN
6505-01-318-7461
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 40 MG. PER ML.,5 ML. PER VIAL
Related Searches:
004554
ARTIFICIAL TEARS SOLUTION
NSN, MFG P/N
6505013187683
NSN
6505-01-318-7683
MFG
ALLERGAN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V CARBOXYMETHYLCELLULOSE SODIUM ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ARTIFICIAL TEARS SOLUTION 0.3ML BOTTLE 30S
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ALLERGAN INC
PRIMARY CONTAINER CONTENT QUANTITY: 0.300 MILLILITERS OR 0.010 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 30
